Data as of Sep 30
| -0.03 / -0.20%|
The 4 analysts offering 12-month price forecasts for Depomed Inc have a median target of 16.50, with a high estimate of 20.00 and a low estimate of 13.50. The median estimate represents a +8.62% increase from the last price of 15.19.
The current consensus among 4 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.